- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Shanghai Johnson & Johnson Pharmaceuticals, Ltd.
I alt 1011 resultater
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetKvindelig prævention | Svangerskabsforebyggelse | Farmakokinetik | Terapeutisk ækvivalens
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetNeoplasmer | Diabetisk fod | Blodplade-afledt vækstfaktor
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetMigræne | Vaskulær hovedpine
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetKræft | Anæmi | Neoplasma
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetManiodepressiv | Mani | Affektiv psykose, bipolar
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetKræft | AnæmiForenede Stater
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetAlzheimers sygdom
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetMigræne | Hovedpine | Almindelig migræne | Klassisk migræne
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetKvindelig prævention | Svangerskabsforebyggelse
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetEpilepsi | Anfald | Epilepsi, Delvis
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetSund og rask | Farmakokinetik | Lægemiddelinteraktioner
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetMyelodysplastisk syndrom
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetSund og rask | Farmakokinetik
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetStørre depressiv lidelseForenede Stater
-
Johnson & Johnson Pte LtdElysia GroupAfsluttetDepressiv lidelse, behandlingsresistent
-
Johnson & Johnson International (Singapore) Pte...AfsluttetHøjrisiko lokaliseret prostatakræftJapan, Korea, Republikken, Taiwan
-
Johnson & Johnson Pharmaceutical Research & Development...Godkendt til markedsføringUrogenitale neoplasmer | Genitale neoplasmer, mandlige | Prostata neoplasmer | Kønssygdomme, mandligeForenede Stater, Australien, Hong Kong, Spanien, Colombia, Mexico, Polen, Malaysia, Rumænien, Canada, Grækenland, Taiwan, Korea, Republikken, New Zealand, Singapore, Brasilien, Den Russiske Føderation, Tjekkiet, Puerto Rico, Th... og mere
-
Johnson & Johnson Pharmaceutical Research & Development...AfsluttetForstoppelseKina, Taiwan, Australien, Korea, Republikken, Thailand
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet
-
Johnson & Johnson Pharmaceutical Research & Development...Afsluttet